We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$220M
AUM Growth
+$30M
Cap. Flow
+$26.2M
Cap. Flow %
11.9%
Top 10 Hldgs %
48.15%
Holding
149
New
17
Increased
36
Reduced
22
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 28.16%
2 Energy 23.78%
3 Financials 6.89%
4 Technology 3.51%
5 Materials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
126
Precigen
PGEN
$2.46B
$227K 0.1%
+5,232
New +$188K
MON
127
DELISTED
Monsanto Co
MON
$225K 0.1%
+2,000
New +$238K
T icon
128
AT&T
T
$168B
$224K 0.1%
9,076
AMLP icon
129
Alerian MLP ETF
AMLP
$13.3B
$223K 0.1%
2,690
FCX icon
130
Freeport-McMoran
FCX
$96.4B
$221K 0.1%
+11,686
New +$231K
AIG icon
131
American International
AIG
$40.4B
$219K 0.1%
4,000
IWF icon
132
iShares Russell 1000 Growth ETF
IWF
$127B
$218K 0.1%
+8,816
New +$215K
JCI icon
133
Johnson Controls International
JCI
$93.7B
$217K 0.1%
4,106
FWONA icon
134
Liberty Media Series A
FWONA
$23.4B
$211K 0.1%
+8,143
New +$204K
VXUS icon
135
Vanguard Total International Stock ETF
VXUS
$162B
$201K 0.09%
+4,000
New +$199K
RYAAY icon
136
Ryanair
RYAAY
$30.8B
$200K 0.09%
7,312
BCRX icon
137
BioCryst Pharmaceuticals
BCRX
$2.64B
$181K 0.08%
20,000
+10,000
+100% +$104K
DARE icon
138
Dare Bioscience
DARE
$21.6M
$180K 0.08%
167
DAR icon
139
Darling Ingredients
DAR
$9.84B
$140K 0.06%
10,000
-7,000
-41% -$115K
IRD
140
Opus Genetics
IRD
$323M
$109K 0.05%
313
VIRX
141
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$27K 0.01%
52
CPRI icon
142
Capri Holdings
CPRI
$1.77B
-4,600
Closed -$345K
MCD icon
143
McDonald's
MCD
$194B
-2,185
Closed -$205K
MU icon
144
Micron Technology
MU
$981B
-15,500
Closed -$543K
FIG
145
DELISTED
Fortress Investment Group Llc
FIG
-13,475
Closed -$108K
DTV
146
DELISTED
DIRECTV COM STK (DE)
DTV
-3,188
Closed -$276K
WPZ
147
DELISTED
Williams Partners L.P.
WPZ
-10,186
Closed -$520K
AUXL
148
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
-10,000
Closed -$344K
CBST
149
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
-2,555
Closed -$257K

Similar funds

Northeast Financial Consultants's Q1 2015 Portfolio in Review

As of Q1 2015, Northeast Financial Consultants held 149 positions worth $220M, up 16% from $190M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Northeast Financial Consultants deployed $26.2M of net new capital in Q1 2015, opening 17 new positions and adding to 36 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 32,245 shares worth $3.46M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was TOWERS WATSON & CO COM STK CL A (DE), an estimated $451K trimmed.

  • Northeast Financial Consultants's largest Q1 2015 buy was Vanguard Morningstar Total Stock Market ETF: 32,245 shares worth $3.46M.
  • Northeast Financial Consultants added most to Invesco Pharmaceuticals ETF in Q1 2015, an estimated $3.63M increase.
  • Northeast Financial Consultants's biggest Q1 2015 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $451K.
  • Northeast Financial Consultants fully exited Micron Technology in Q1 2015, selling an estimated $543K.
  • Northeast Financial Consultants's ten largest holdings make up 48% of its $220M portfolio in Q1 2015.
  • Northeast Financial Consultants opened 17 new positions and closed 8 in Q1 2015.
  • Northeast Financial Consultants's portfolio value rose 16% quarter-over-quarter to $220M.

Based on Northeast Financial Consultants's 13F filing for Q1 2015, filed 8 May 2015.